vs
Side-by-side financial comparison of Canaan Inc. (CAN) and LENZ Therapeutics, Inc. (LENZ). Click either name above to swap in a different company.
Canaan Inc. is the larger business by last-quarter revenue ($20.8M vs $12.5M, roughly 1.7× LENZ Therapeutics, Inc.). Canaan Inc. runs the higher net margin — -18.4% vs -133.6%, a 115.2% gap on every dollar of revenue.
Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.
LENZ Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing novel ophthalmic therapies. Its lead product candidates address presbyopia, the age-related loss of near vision, catering to global patient groups with unmet medical needs in the eye care sector.
CAN vs LENZ — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.8M | $12.5M |
| Net Profit | $-3.8M | $-16.7M |
| Gross Margin | 99.9% | — |
| Operating Margin | -15.9% | -151.1% |
| Net Margin | -18.4% | -133.6% |
| Revenue YoY | — | — |
| Net Profit YoY | — | -63.5% |
| EPS (diluted) | $-0.05 | $-0.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.8M | — | ||
| Q3 25 | $13.8M | $12.5M | ||
| Q2 25 | $11.4M | $5.0M | ||
| Q3 24 | $10.2M | $0 | ||
| Q2 24 | $4.8M | $0 |
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $-1.5M | $-16.7M | ||
| Q2 25 | $-11.9M | $-14.9M | ||
| Q3 24 | $-10.4M | $-10.2M | ||
| Q2 24 | $-5.4M | $-10.3M |
| Q4 25 | 99.9% | — | ||
| Q3 25 | 99.9% | — | ||
| Q2 25 | 99.9% | — | ||
| Q3 24 | 99.9% | — | ||
| Q2 24 | 99.8% | — |
| Q4 25 | -15.9% | — | ||
| Q3 25 | -27.0% | -151.1% | ||
| Q2 25 | -45.5% | -337.1% | ||
| Q3 24 | -77.2% | — | ||
| Q2 24 | -193.9% | — |
| Q4 25 | -18.4% | — | ||
| Q3 25 | -11.0% | -133.6% | ||
| Q2 25 | -104.4% | -298.2% | ||
| Q3 24 | -102.7% | — | ||
| Q2 24 | -112.3% | — |
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.02 | $-0.59 | ||
| Q2 25 | $-0.25 | $-0.53 | ||
| Q3 24 | — | $-0.38 | ||
| Q2 24 | — | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $25.4M |
| Total DebtLower is stronger | $6.2M | — |
| Stockholders' EquityBook value | $52.4M | $193.9M |
| Total Assets | $92.5M | $210.7M |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $25.4M | ||
| Q2 25 | — | $37.6M | ||
| Q3 24 | — | $41.0M | ||
| Q2 24 | — | $84.0M |
| Q4 25 | $6.2M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $6.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | $52.4M | — | ||
| Q3 25 | $44.7M | $193.9M | ||
| Q2 25 | $33.8M | $206.4M | ||
| Q3 24 | $43.6M | $215.3M | ||
| Q2 24 | $56.8M | $192.9M |
| Q4 25 | $92.5M | — | ||
| Q3 25 | $81.7M | $210.7M | ||
| Q2 25 | $78.0M | $217.3M | ||
| Q3 24 | $69.3M | $224.0M | ||
| Q2 24 | $73.7M | $202.6M |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.18× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-8.6M |
| Free Cash FlowOCF − Capex | — | $-9.0M |
| FCF MarginFCF / Revenue | — | -72.2% |
| Capex IntensityCapex / Revenue | — | 3.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-47.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $-8.6M | ||
| Q2 25 | — | $-11.5M | ||
| Q3 24 | — | $-10.6M | ||
| Q2 24 | — | $-15.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-9.0M | ||
| Q2 25 | — | $-11.7M | ||
| Q3 24 | — | $-10.8M | ||
| Q2 24 | — | $-15.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | -72.2% | ||
| Q2 25 | — | -235.0% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.5% | ||
| Q2 25 | — | 4.8% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
